[CTXR] YoY Quarter Result on 31-Dec-2022 [#Q1]

Stock
[CTXR] Citius Pharmaceuticals, Inc.
Announcement Date
10-Feb-2023
Financial Year
2023
Quarter
31-Dec-2022 [#Q1]
Profit Trend
QoQ- 55.02%
YoY- 61.04%
Quarter Report
CTXR's Result
CTXR's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -9,087 -3,450 -9,225 -8,147 -4,322 -3,875 -3,246 18.70%
Tax 144 144 34 13 114 2 0 -
NP -9,231 -3,594 -9,225 -8,147 -4,322 -3,875 -3,246 19.01%
Tax Rate - - - - - - - -
Total Cost 9,231 3,594 9,225 8,147 4,322 3,875 3,246 19.01%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.06 -0.02 -0.06 -0.15 -0.15 -0.22 -0.38 -26.47%
EPS Diluted -0.06 -0.02 -0.06 -0.15 -0.15 -0.22 -0.38 -26.47%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.